Financials

  • Market Capitalization 10.46 B
  • Employee 691
  • Founded 2014
  • CEO Rich Adcock
  • Website www.immunitybio.com
  • Headquarter Delaware, United States
  • FIGI BBG007T9DYW9
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-5.21
市销率
16.08

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
862
BMRN
BioMarin Pharmaceutical Inc. - Common Stock
54.36 USD-1.86%-4.33%-18.26%+4.98%10.52 B USD
867
MDGL
Madrigal Pharmaceuticals, Inc. - Common Stock
453.55 USD-2.91%-8.97%-16.01%+7.07%10.48 B USD
878
PCVX
Vaxcyte, Inc. - Common Stock
68.84 USD-2.56%+4.32%+14.66%+62.74%10.24 B USD
888
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
79.16 USD-0.10%+3.90%+1.63%+99.67%10.07 B USD

新闻